Omega 3 FA Supplements as Augmentation in the Treatment of Depression

NCT01803711 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Lack of recruitment and no resources

Conditions

Major Depression
Cancer
Diabetes
Cardiovascular Diseases

Interventions

DRUG: Desvenlafaxine
DIETARY_SUPPLEMENT: Omega 3 Fatty acids
DRUG: Placebo (for Omega 3 fatty acid supplement)

Sponsor

UConn Health